Pathogenetix, Inc. logo — Harnessing advanced genomics for speedy, cost-effective path...

Pathogenetix, Inc.

Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics.

Founded 1997 6 employees Series C Total: $28.37M Biotechnology, Health Care

General Information

Company Name Pathogenetix, Inc.
Founded Year 1997
Employees 6
Industries Biotechnology, Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Pathogenetix, Inc.. To contact Pathogenetix, Inc., visit pathogenetix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pathogenetix, Inc. compare?

A PDF of Pathogenetix, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pathogenetix, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pathogenetix, Inc.

Pathogenetix, Inc. is a biotechnology startup dedicated to revolutionizing pathogen detection across various industries. The company's slogan, "Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics," reflects their core mission. Founded in 1997, Pathogenetix has developed an automated system utilizing Genome Sequence Scanning Technology to swiftly identify harmful bacterial strains. Their innovative method, involving a single reagent set to produce genomic barcodes from bacterial DNA, enables the cost-effective identification of thousands of strains within three hours. The company's GSS platform is poised to address applications in genomics research, food and product safety testing, and clinical infectious disease diagnostics. Notably, their Series C investment of $10.00M on 30 October 2013 saw participation from prominent firms including Ascension Ventures, Excel Venture Management, and HealthCare Ventures. With plans for an initial commercial launch in the research market in 2012, Pathogenetix is positioned to make a significant impact in the field of pathogen detection and genome sequencing.

Business keywords: genomics, pathogen detection, bacterial strains, genome sequencing, food safety, clinical diagnostics, automated system, proprietary technology, product safety testing, infectious disease diagnostics, GSS platform, rapid identification, DNA barcoding, commercial launch

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $10.00M 3
Ascension Ventures, Excel Venture Management +1
30 Oct 2013
Series B $7.50M 4
Ascension Ventures, Excel Venture Management +2
01 Nov 2011
Series B $4.00M 3
Excel Venture Management, HealthCare Ventures +1
01 Aug 2011
Venture Round $1.51M -
13 Dec 2010
Debt Financing $1.00M -
19 Jan 2010
Series A $4.36M 2
HealthCare Ventures, CB Health Ventures
14 Jul 2008

Pathogenetix, Inc. Alternatives & Competitors

View All Alternatives
Pathogenetix, Inc. vs
Clear Labs
Clear Labs United States

Provider of fully automated next generation sequencing platforms, software and robotics for turnkey...

Series D
86 employees
AI, Biotechnology
Pathogenetix, Inc. vs

The future of infectious disease diagnostics starts at Day Zero.

64 employees
Biotechnology, Health Care
Pathogenetix, Inc. vs
CosmosID
CosmosID United States

Unlocking The Microbiome

Series B
30 employees
Biotechnology, Health Care

FAQ About Pathogenetix, Inc.

Harnessing advanced genomics for speedy, cost-effective pathogen detection across research, food safety, and clinical diagnostics.
Pathogenetix, Inc. was founded in 1997.
Pathogenetix, Inc. operates in Biotechnology and Health Care. Its work centres on genomics, pathogen detection, bacterial strains and genome sequencing.
Pathogenetix, Inc. has approximately 6 employees.
Pathogenetix, Inc. has completed 6 funding rounds, raising a total of $28.37M. The latest funding stage is Series C.
Top alternatives and competitors to Pathogenetix, Inc. include Clear Labs, Day Zero Diagnostics, Inc, CosmosID, OmniVis, First Light Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pathogenetix, Inc. and Clear Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pathogenetix, Inc., https://bouncewatch.com/company/pathogenetix-inc, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes